Incannex Healthcare (IXHL) Other Non-Current Liabilities (2020 - 2026)

Incannex Healthcare (IXHL) posted quarterly Other Non-Current Liabilities of $3.1 million for Q1 2026, up 132.98% year-on-year from $1.3 million in Q1 2025, and up 132.98% on a QoQ basis from $1.3 million in Q1 2025.

Incannex Healthcare (IXHL) Other Non-Current Liabilities (2020 - 2026) Analysis & Trends

Incannex Healthcare (IXHL) has reported Other Non-Current Liabilities for 4 consecutive years, with $3.1 million the latest figure, recorded in Q1 2026.

  • Quarterly Other Non-Current Liabilities rose 132.98% year-over-year to $3.1 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $3.1 million (up 132.98% YoY) and the FY2020 annual result came in at $116645.0, changed N/A from the prior year.
  • Other Non-Current Liabilities rose to $3.1 million in Q1 2026 per IXHL's latest filing, from $1.3 million in the prior quarter.
  • Over the last five years, Other Non-Current Liabilities for IXHL reached as high as $3.1 million in Q1 2026 and fell as low as $1.3 million in Q4 2024.
  • A 3-year average of $1.9 million and a median of $1.3 million in 2025 frame the typical range for Other Non-Current Liabilities.
  • The largest YoY upside for Other Non-Current Liabilities was 132.98% in 2026 against a maximum downside of 132.98% in 2026.
  • Year by year, Other Non-Current Liabilities stood at $1.3 million in 2024, then grew by 2.8% to $1.3 million in 2025, then surged by 132.98% to $3.1 million in 2026.
  • According to Business Quant data, Other Non-Current Liabilities over the past three periods registered $3.1 million, $1.3 million, and $1.3 million for Q1 2026, Q1 2025, and Q4 2024 respectively.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Haleon 87.22 Bn 85.35 Bn -
2 Teva Pharmaceutical Industries 39.60 Bn 35.87 Bn 1.97 Bn
3 Zoetis 31.46 Bn 29.52 Bn 1.62 Bn
4 Takeda Pharmaceutical 26.49 Bn 22.44 Bn 4.39 Bn
5 United Therapeutics 23.03 Bn 20.88 Bn 648.10 Mn
6 Universe Pharmaceuticals 23.03 Bn -10.56 Bn -
7 Viatris 20.90 Bn 19.09 Bn 1.16 Bn
8 Neurocrine Biosciences 17.50 Bn 16.19 Bn 800.70 Mn
9 Elanco Animal Health 12.33 Bn 11.91 Bn 785.00 Mn
10 Incannex Healthcare 3.63 Mn 3.63 Mn -

Historic Data

Download Data
DateValue
Mar 31, 2026 3.08 Mn
Mar 31, 2025 1.32 Mn
Dec 31, 2024 1.29 Mn
Jun 30, 2020 116,645.00